Friday, September 3, 2010
"Concise industry news from the US pharmaceutical industry..."
You could argue that anything done in a new way, however small, can be counted as an innovation. Introducing innovation at a game-changing level, however, is not so simple, and it's only going to get harder for the pharmaceutical industry.
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Peter Duncan
Director of Business Development
Director of Business Development
Next Generation Healthcare Summit
25th - 27th October 2010
As healthcare costs continue to rise, health providers around the country feel a sharp sense of urgency in deploying information technology to lower costs, reduce medical errors, enhance outcomes, and spur efficiency in an industry known for legendary inefficiency.
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.